RMC No. 157-2022: Updated VAT-Exempt Medicines List for Mental Illness and COVID-19 Treatment Under the CREATE Act

RMC No. 157-2022 updates the VAT-exempt medicines list under the CREATE Act, covering certain mental illness and COVID-19 treatment medicines. Pharmacies, hospitals, clinics, drug distributors, and sellers of covered medicines must verify whether their products are included in the updated List of VAT-Exempt Medicines because the VAT exemption applies only from the date the Food […]

RMC No. 125-2022: Updated FDA List Deletes Certain COVID-19 Treatment Medicines from CREATE Act VAT Exemption

RMC No. 125-2022 updates the FDA VAT-exempt medicines list, deleting certain COVID-19 treatment medicines under the CREATE Act. Businesses selling, purchasing, importing, distributing, prescribing, or accounting for medicines used in COVID-19 treatment must immediately re-check the current FDA-published List of VAT-Exempt Medicines before treating those medicines as VAT-exempt. RMC No. 125-2022 makes a critical update […]

RMC No. 124-2022: VAT-Exempt Medicines Updated for Cancer, Tuberculosis, Mental Illness, Diabetes, and Hypertension Under CREATE

RMC No. 124-2022 updates VAT-exempt medicines under CREATE for cancer, tuberculosis, mental illness, diabetes, and hypertension based on FDA publication. Businesses selling, importing, prescribing, dispensing, accounting for, or claiming VAT treatment on covered medicines must check the updated VAT-exempt medicine list immediately because the exemption applies based on the date the Food and Drug Administration […]

RMC No. 116-2022: Updated VAT-Exempt Medicines List for Hypertension, Diabetes, Kidney Disease, Mental Illness, Cancer, and Deleted COVID-19 Medicines

RMC No. 116-2022 updates the VAT-exempt medicines list under CREATE, adding certain chronic disease medicines and deleting some COVID-19 medicines. Pharmacies, hospitals, clinics, distributors, importers, and accounting teams handling medicines must immediately check whether their products remain VAT-exempt, newly qualify for VAT exemption, or have been removed from the VAT-exempt list. RMC No. 116-2022 confirms […]

RMC No. 110-2022: VAT Exemption Updates for Certain Cancer and COVID-19 Medicines Under the CREATE Act

RMC No. 110-2022 updates VAT-exempt medicines under CREATE, covering certain cancer and COVID-19 medicines effective upon FDA publication. Businesses selling, purchasing, importing, prescribing, or accounting for medicines used in cancer and COVID-19 treatment must verify whether the specific medicines they handle are now included in the updated List of VAT-Exempt Medicines. RMC No. 110-2022 matters […]

RMC No. 83-2022: Updated VAT-Exempt Medicines List for Diabetes, Hypertension, Mental Illness, Cancer, and Kidney Disease Drugs

RMC No. 83-2022 updates the VAT-exempt medicines list under CREATE, covering diabetes, hypertension, mental illness, cancer, and kidney disease drugs. Businesses that manufacture, import, distribute, sell, prescribe, dispense, procure, or account for medicines must immediately review their VAT treatment because RMC No. 83-2022 confirms updates to the List of VAT-Exempt Medicines under Republic Act No. […]

RMC No. 68-2022: Updated VAT-Exempt Medicines List for Hypertension, Diabetes, Cancer, COVID-19 and Other Treatments

RMC No. 68-2022 updates the FDA-endorsed VAT-exempt medicines list under CREATE for key disease categories including COVID-19 and cancer. Pharmacies, hospitals, clinics, distributors, importers, and VAT-registered sellers of medicines must check whether their covered products are included in the updated VAT-exempt medicines list endorsed by the Food and Drug Administration, because qualifying medicines for hypertension, […]

RMC No. 66-2022: Updated VAT-Exempt Medical Devices for COVID-19 Treatment Under the CREATE Act

RMC No. 66-2022 updates the FDA-endorsed VAT-exempt list for certain COVID-19 treatment medical devices under the CREATE Act. Businesses selling, importing, purchasing, or claiming VAT treatment on COVID-19-related medical devices must immediately check whether their products remain covered by the updated VAT-exempt list endorsed by the Food and Drug Administration. RMC No. 66-2022 matters because […]

RMC No. 59-2022: VAT-Exempt Medicines for Cancer and COVID-19 Treatment Under the CREATE Act

RMC No. 59-2022 updates the VAT-exempt medicine list under CREATE to include certain cancer and COVID-19 treatment medicines. Businesses selling, purchasing, prescribing, distributing, or accounting for qualified medicines for cancer and COVID-19 treatment must check whether their products are covered by the updated List of VAT-Exempt Medicines under Republic Act No. 11534, or the CREATE […]

RMC No. 56-2022: VAT-Exempt Medicines List Updated for Hypertension and COVID-19 Treatment Under CREATE Act

RMC No. 56-2022 updates the VAT-exempt medicines list for hypertension and COVID-19 treatment under the CREATE Act, requiring item-level VAT review. Pharmacies, hospitals, distributors, importers, clinics, and businesses selling or purchasing medicines for hypertension and COVID-19 treatment should immediately review their VAT treatment because RMC No. 56-2022 updates the List of VAT-Exempt Medicines under Republic […]